The North America Primary Biliary Cholangitis Market is supported by established pharmaceutical networks, rising healthcare expenditure, and growing emphasis on early diagnosis and monitoring of progressive liver conditions. The United States remains a major regional contributor, while Canada is also strengthening access to specialized liver disease care. The Primary Biliary Cholangitis Market...